CAS Medical Systems (NASDAQ:CASM) was downgraded by Craig Hallum from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, The Fly reports.
NASDAQ:CASM opened at $2.41 on Tuesday. CAS Medical Systems has a 52 week low of $0.99 and a 52 week high of $2.70. The firm has a market capitalization of $45.80 million, a price-to-earnings ratio of -8.93 and a beta of 0.45.
A number of hedge funds have recently added to or reduced their stakes in CASM. BlackRock Inc. raised its holdings in shares of CAS Medical Systems by 569.2% during the second quarter. BlackRock Inc. now owns 84,091 shares of the medical technology company’s stock worth $164,000 after acquiring an additional 71,525 shares during the period. Renaissance Technologies LLC raised its stake in shares of CAS Medical Systems by 47.2% during the second quarter. Renaissance Technologies LLC now owns 386,539 shares of the medical technology company’s stock worth $754,000 after acquiring an additional 123,939 shares in the last quarter. Douglas Lane & Associates LLC bought a new stake in CAS Medical Systems in the fourth quarter valued at $54,000. Ingalls & Snyder LLC bought a new position in CAS Medical Systems in the 3rd quarter worth about $1,142,000. Finally, Vanguard Group Inc increased its position in shares of CAS Medical Systems by 2.8% during the 3rd quarter. Vanguard Group Inc now owns 547,560 shares of the medical technology company’s stock valued at $1,249,000 after purchasing an additional 15,155 shares during the last quarter. Institutional investors own 27.92% of the company’s stock.
CAS Medical Systems, Inc, a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations.
Recommended Story: Understanding Analyst Ratings
Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.